You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

magnetic resonance spectroscopy imaging

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial (Magnetic Resonance Spectroscopy Imaging (MRSI))

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Magnetic Resonance Spectroscopy Imaging (MRSI)
  • (no location specified)
Mar 8, 2023

Benign Breast Tumor, Breast Carcinoma, Malignant Breast Tumor Trial in Los Angeles (Diffusion Weighted Imaging, Magnetic

Completed
  • Benign Breast Neoplasm
  • +2 more
  • Diffusion Weighted Imaging
  • Magnetic Resonance Spectroscopic Imaging
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023

Non-Invasive Magnetic Resonance Imaging and Magnetic Resonance

Completed
  • Breast Cancer
  • Magnetic Resonance Imaging (MRI)
  • Magnetic Resonance Spectroscopy (MRS)
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 27, 2022

Quantitative HP MRI for Clinical Prostate Cancer Exam

Active, not recruiting
  • Prostate Adenocarcinoma
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San

Recruiting
  • Recurrent World Health Organization (WHO) Grade II Glioma
  • +3 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Dec 21, 2022

Autoimmune Mechanisms in Fibromyalgia

Completed
  • Fibromyalgia
  • Questionnaires, quantitative sensory testing, blood sampling, skin biopsies, functional magnetic resonance imaging, magnetic resonance spectroscopy
  • Stockholm, Sweden
    Karolinska Insitutet
Apr 3, 2023

Primary Brain Tumor Trial in Houston (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Spectroscopic Imaging)

Recruiting
  • Primary Brain Neoplasm
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Spectroscopic Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Functional Neurological Symptom Disorder, Paralysis, Conversion Disorder With Weakness/Paralysis Trial (Magnetic Resonance

Recruiting
  • Functional Neurological Symptom Disorder
  • +2 more
  • Magnetic Resonance Imaging (MRI)
  • Nottwil, Lucerne, Switzerland
    Swiss Paraplegic Centre
Nov 3, 2022

Alzheimer, Magnetic Resonance Spectroscopy, Ultra High Field 7T Trial (MRI follow-up)

Not yet recruiting
  • Alzheimer Disease
  • +4 more
  • MRI follow-up
  • (no location specified)
Jun 30, 2023

Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C

Active, not recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Spectroscopic Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Malignant Brain Glioma Trial in Atlanta (Magnetic Resonance Spectroscopic Imaging, Proton Therapy)

Recruiting
  • Malignant Brain Glioma
  • Magnetic Resonance Spectroscopic Imaging
  • Proton Therapy
  • Atlanta, Georgia
  • +2 more
May 27, 2022

Malignant CNS Tumor Trial in Rochester (drug, other, procedure)

Not yet recruiting
  • Malignant Central Nervous System Neoplasm
  • Anhydrous Enol-oxaloacetate
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 31, 2023

High-field Brain Magnetic Resonance Spectroscopy

Active, not recruiting
  • Healthy
    • Minneapolis, Minnesota
      Center for Magnetic Resonance Research
    Mar 17, 2022

    Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance

    Recruiting
    • Prostate Adenocarcinoma
    • Prostate Cancer
    • Hyperpolarized Carbon C 13 Pyruvate
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Oct 3, 2022

    Heart Failure With Preserved Ejection Fraction, Obesity Trial in Oxford (Diet intervention)

    Recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Obesity
    • Diet intervention
    • Oxford, United Kingdom
      Oxford Centre for Clinical Magnetic Resonance Research, John Rad
    May 23, 2023

    Magnetic Resonance Spectroscopy Trial in Bern (NIMM_MRS)

    Recruiting
    • Magnetic Resonance Spectroscopy
    • NIMM_MRS
    • Bern, PhD, Switzerland
      Translational Imaging Center
    Jun 7, 2022

    Head and Neck Squamous Cell Carcinoma, Magnetic Resonance Imaging, Neoadjuvant Therapy Trial in Guangzhou

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital
      Jul 27, 2023

      Brain Tumors by Advanced MRI

      Completed
      • Glioblastoma
      • Avastin
      • +5 more
      • Boston, Massachusetts
        Massachusetts general Hospital
      Apr 6, 2022

      Heart Failure, Heart Failure With Reduced Ejection Fraction, Obesity Trial in Oxford (Diet intervention)

      Recruiting
      • Heart Failure
      • +3 more
      • Diet intervention
      • Oxford, United Kingdom
        Jenny Rayner
      Jul 3, 2023

      MRI and PET Imaging in Predicting Treatment Response in Stage

      Active, not recruiting
      • Cervical Adenocarcinoma
      • +12 more
      • Computed Tomography
      • +5 more
      • Miami, Florida
      • +5 more
      Oct 4, 2022

      Depression Trial in Montpellier (Magnetic Resonance Imaging (MRI) and biological samples)

      Completed
      • Depression
      • Magnetic Resonance Imaging (MRI) and biological samples
      • Montpellier, France
        Montpellier Hospital University
      Dec 20, 2021

      Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized

      Enrolling by invitation
      • Breast Cancer
      • +3 more
      • Copenhagen, Denmark
        Rigshospitalet
      Jan 18, 2023

      Heart Failure With Preserved Ejection Fraction, Heart Failure, Diastolic, Diabetes, Type 2 Trial in Leicester, Manchester,

      Recruiting
      • Heart Failure With Preserved Ejection Fraction
      • +4 more
      • Low calorie meal replacement plan
      • +12 more
      • Leicester, Leicestershire, United Kingdom
      • +2 more
      May 31, 2023

      Diagnostic Technics, Neurological Trial in Toronto (diagnostic test, other, device)

      Not yet recruiting
      • Diagnostic Technics, Neurological
      • Single-voxel MRS
      • +5 more
      • Toronto, Ontario, Canada
        Sunnybrook Research Institute
      Oct 3, 2022

      Malignant CNS Tumor, Metastatic Malignant Tumor in the CNS Trial in Palo Alto (other, drug, procedure)

      Suspended
      • Malignant Central Nervous System Neoplasm
      • Metastatic Malignant Neoplasm in the Central Nervous System
      • Gadolinium
      • +3 more
      • Palo Alto, California
        Stanford University School of Medicine
      Aug 2, 2021